An Assessment of the 4-6-20 Rule for Acceptance of Analytical Runs in Bioavailability, Bioequivalence, and Pharmacokinetic Studies
- 1 January 1994
- journal article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 11 (4) , 556-560
- https://doi.org/10.1023/a:1018922701174
Abstract
A recent conference report described a decision rule, hereafter referred to as the 4-6-20 rule, for acceptance/rejection of analytical runs in bioavailability, bioequivalence, and pharmacokinetic...Keywords
This publication has 2 references indexed in Scilit:
- A retrospective assessment of the 75/75 rule in bioequivalenceStatistics in Medicine, 1992
- Statistical Simulation Study of New Proposed Uniformity Requirement for Bioequivalency StudiesJournal of Pharmaceutical Sciences, 1981